AEterna Zentaris to Present at Upcoming Canaccord Genuity Global Growth Conference in Boston

Published: Aug 07, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

QUÉBEC CITY, Aug. 7, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's Senior Vice President and CFO, Dennis Turpin, CPA, CA, will be presenting a corporate overview at the Canaccord Genuity 33rd Annual Global Growth Conference on Wednesday, August 14, 2013, at 11:00 am (Eastern), in the Paris Room of the Intercontinental Boston Hotel.

A live audio webcast of this presentation will be available on Aeterna Zentaris' website at in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval. For more information, visit

SOURCE Aeterna Zentaris Inc.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news